Skip to main content
SpringerLink
Log in
Book cover

Hilar Cholangiocarcinoma pp 167–185Cite as

Selection of Patients for Liver Resection and Liver Transplantation

  • Chapter
  • First Online:

  • 1744 Accesses

Abstract

Complete excision of viable tumor offers the only chance for cure for hilar cholangiocarcinoma. Resection and liver transplantation have each evolved to offer significant survival advantages over non-surgical treatments. Although the two options beg comparison, currently the indications for each are different.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Abu-Elmagd KM, Malinchoc M, Dickson ER, et al. Efficacy of hepatic transplantation in patients with primary sclerosing cholangitis. Surg Gynecol Obstet. 1993;177:335–44.

    PubMed  CAS  Google Scholar 

  2. Ahrendt SA, Pitt HA, Nakeeb A, et al. Diagnosis and management of cholangiocarcinoma in primary sclerosing cholangitis. J Gastrointest Surg. 1999;3:357–67; discussion 67–8.

    Article  PubMed  CAS  Google Scholar 

  3. Becker NS, Rodriguez JA, Barshes NR, et al. Outcomes analysis for 280 patients with cholangiocarcinoma treated with liver transplantation over an 18-year period. J Gastrointest Surg. 2008;12:117–22.

    Article  PubMed  Google Scholar 

  4. Brandsaeter B, Isoniemi H, Broome U, et al. Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy. J Hepatol. 2004;40:815–22.

    Article  PubMed  CAS  Google Scholar 

  5. Ghali P, Marotta PJ, Yoshida EM, et al. Liver transplantation for incidental cholangiocarcinoma: analysis of the Canadian experience. Liver Transpl. 2005;11:1412–6.

    Article  PubMed  Google Scholar 

  6. Goldstein RM, Stone M, Tillery GW, et al. Is liver transplantation indicated for cholangiocarcinoma? Am J Surg. 1993;166:768–71; discussion 71–2.

    Article  PubMed  CAS  Google Scholar 

  7. Goss JA, Shackleton CR, Farmer DG, et al. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience. Ann Surg. 1997;225:472–81; discussion 81–3.

    Article  PubMed  CAS  Google Scholar 

  8. Iwatsuki S, Todo S, Marsh JW, et al. Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation. J Am Coll Surg. 1998;187:358–64.

    Article  PubMed  CAS  Google Scholar 

  9. Lindner P, Norrby J, Olausson M, et al. Survival after liver transplantation for cholangiocarcinoma has increased during the last decade. Transplant Proc. 2003;35:811–2.

    Article  PubMed  CAS  Google Scholar 

  10. Meyer CG, Penn I, James L. Liver transplantation for cholangiocarcinoma: results in 207 patients. Transplantation. 2000;69:1633–7.

    Article  PubMed  CAS  Google Scholar 

  11. Rea DJ, Rosen CB, Nagorney DM, et al. Transplantation for cholangiocarcinoma: when and for whom? Surg Oncol Clin N Am. 2009;18:325–37, ix.

    Article  PubMed  Google Scholar 

  12. Robles R, Figueras J, Turrion VS, et al. Spanish experience in liver transplantation for hilar and peripheral cholangiocarcinoma. Ann Surg. 2004;239:265–71.

    Article  PubMed  Google Scholar 

  13. Heimbach JK, Gores GJ, Nagorney DM, et al. Liver transplantation for perihilar cholangiocarcinoma after aggressive neoadjuvant therapy: a new paradigm for liver and biliary malignancies? Surgery. 2006;140:331–4.

    Article  PubMed  Google Scholar 

  14. Rea DJ, Heimbach JK, Rosen CB, et al. Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg. 2005;242:451–8.

    PubMed  Google Scholar 

  15. Schwartz JJ, Hutson WR, Gayowski TJ, et al. Liver transplantation for cholangiocarcinoma. Transplantation. 2009;88:295–8.

    Article  PubMed  Google Scholar 

  16. Bismuth H, Corlette MB. Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet. 1975;140:170–8.

    PubMed  CAS  Google Scholar 

  17. Bismuth H, Nakache R, Diamond T. Management strategies in resection for hilar cholangiocarcinoma. Ann Surg. 1992;215:31–8.

    Article  PubMed  CAS  Google Scholar 

  18. Chen XP, Lau WY, Huang ZY, et al. Extent of liver resection for hilar cholangiocarcinoma. Br J Surg. 2009;96:1167–75.

    Article  PubMed  Google Scholar 

  19. Dinant S, Gerhards MF, Busch OR, et al. The importance of complete excision of the caudate lobe in resection of hilar cholangiocarcinoma. HPB (Oxford). 2005;7:263–7.

    Article  Google Scholar 

  20. Hirano S, Kondo S, Tanaka E, et al. No-touch resection of hilar malignancies with right hepatectomy and routine portal reconstruction. J Hepatobiliary Pancreat Surg. 2009;16:502–7.

    Article  PubMed  Google Scholar 

  21. Ito F, Agni R, Rettammel RJ, et al. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence. Ann Surg. 2008;248:273–9.

    Article  PubMed  Google Scholar 

  22. Ito F, Cho CS, Rikkers LF, et al. Hilar cholangiocarcinoma: current management. Ann Surg. 2009;250:210–8.

    Article  PubMed  Google Scholar 

  23. Jarnagin WR, Shoup M. Surgical management of cholangiocarcinoma. Semin Liver Dis. 2004;24:189–99.

    Article  PubMed  Google Scholar 

  24. Hemming AW, Magliocca JF, Fujita S, et al. Combined resection of the liver and pancreas for malignancy. J Am Coll Surg. 2010;210:808–16.

    Article  PubMed  Google Scholar 

  25. Bergquist A, Glaumann H, Persson B, et al. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study. Hepatology. 1998;27:311–6.

    Article  PubMed  CAS  Google Scholar 

  26. Broome U, Olsson R, Loof L, et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut. 1996;38:610–5.

    Article  PubMed  CAS  Google Scholar 

  27. Farges O, Malassagne B, Sebagh M, et al. Primary sclerosing cholangitis: liver transplantation or biliary surgery. Surgery. 1995;117:146–55.

    Article  PubMed  CAS  Google Scholar 

  28. Ramage JK, Donaghy A, Farrant JM, et al. Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. Gastroenterology. 1995;108:865–9.

    Article  PubMed  CAS  Google Scholar 

  29. Rosen CB, Nagorney DM, Wiesner RH, et al. Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann Surg. 1991;213:21–5.

    Article  PubMed  CAS  Google Scholar 

  30. Marsh Jr JW, Iwatsuki S, Makowka L, et al. Orthotopic liver transplantation for primary sclerosing cholangitis. Ann Surg. 1988;207:21–5.

    Article  PubMed  Google Scholar 

  31. Mahadevan U, Bass N. Sclerosing cholangitis and recurrent pyogenic cholangitis. In: Feldman M, Friedman LS, Scleisenger MH, editors. Gastrointestinal and liver disease: pathophysiology diagnosis management. Philadelphia: Saunders; 2003. p. 1131.

    Google Scholar 

  32. Erichsen R, Jepsen P, Vilstrup H, et al. Incidence and prognosis of cholangiocarcinoma in Danish patients with and without inflammatory bowel disease: a national cohort study, 1978—2003. Eur J Epidemiol. 2009;24:513–20.

    Article  PubMed  Google Scholar 

  33. Singal A, Welling TH, Marrero JA. Role of liver transplantation in the treatment of cholangiocarcinoma. Expert Rev Anticancer Ther. 2009;9:491–502.

    Article  PubMed  Google Scholar 

  34. Malhi H, Gores GJ. Cholangiocarcinoma: modern advances in understanding a deadly old disease. J Hepatol. 2006;45:856–67.

    Article  PubMed  CAS  Google Scholar 

  35. Patel AH, Harnois DM, Klee GG, et al. The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis. Am J Gastroenterol. 2000;95:204–7.

    Article  PubMed  CAS  Google Scholar 

  36. Petrowsky H, Hong JC. Current surgical management of hilar and intrahepatic cholangiocarcinoma: the role of resection and orthotopic liver transplantation. Transplant Proc. 2009;41:4023–35.

    Article  PubMed  CAS  Google Scholar 

  37. Vestergaard EM, Hein HO, Meyer H, et al. Reference values and biological variation for tumor marker CA 19-9 in serum for ­different Lewis and secretor genotypes and evaluation of secretor and Lewis genotyping in a Caucasian population. Clin Chem. 1999;45:54–61.

    PubMed  CAS  Google Scholar 

  38. Hann LE, Greatrex KV, Bach AM, et al. Cholangiocarcinoma at the hepatic hilus: sonographic findings. AJR Am J Roentgenol. 1997;168:985–9.

    Article  PubMed  CAS  Google Scholar 

  39. Okuda K, Ohto M, Tsuchiya Y. The role of ultrasound, percutaneous transhepatic cholangiography, computed tomographic scanning, and magnetic resonance imaging in the preoperative assessment of bile duct cancer. World J Surg. 1988;12:18–26.

    Article  PubMed  CAS  Google Scholar 

  40. Manfredi R, Barbaro B, Masselli G, et al. Magnetic resonance imaging of cholangiocarcinoma. Semin Liver Dis. 2004;24:155–64.

    Article  PubMed  Google Scholar 

  41. Yeh TS, Jan YY, Tseng JH, et al. Malignant perihilar biliary obstruction: magnetic resonance cholangiopancreatographic findings. Am J Gastroenterol. 2000;95:432–40.

    Article  PubMed  CAS  Google Scholar 

  42. Zhang Y, Uchida M, Abe T, et al. Intrahepatic peripheral cholangiocarcinoma: comparison of dynamic CT and dynamic MRI. J Comput Assist Tomogr. 1999;23:670–7.

    Article  PubMed  CAS  Google Scholar 

  43. Peterson MS, Murakami T, Baron RL. MR imaging patterns of gadolinium retention within liver neoplasms. Abdom Imaging. 1998;23:592–9.

    Article  PubMed  CAS  Google Scholar 

  44. Lee MG, Park KB, Shin YM, et al. Preoperative evaluation of hilar cholangiocarcinoma with contrast-enhanced three-dimensional fast imaging with steady-state precession magnetic resonance angiography: comparison with intraarterial digital subtraction angiography. World J Surg. 2003;27:278–83.

    Article  PubMed  Google Scholar 

  45. Kim JY, Kim MH, Lee TY, et al. Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma: a ­prospective study compared with conventional imaging. Am J Gastroenterol. 2008;103:1145–51.

    Article  PubMed  Google Scholar 

  46. Petrowsky H, Wildbrett P, Husarik DB, et al. Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma. J Hepatol. 2006;45:43–50.

    Article  PubMed  Google Scholar 

  47. Henke AC, Jensen CS, Cohen MB. Cytologic diagnosis of adenocarcinoma in biliary and pancreatic duct brushings. Adv Anat Pathol. 2002;9:301–8.

    Article  PubMed  Google Scholar 

  48. Layfield LJ, Wax TD, Lee JG, et al. Accuracy and morphologic aspects of pancreatic and biliary duct brushings. Acta Cytol. 1995;39:11–8.

    PubMed  CAS  Google Scholar 

  49. de Bellis M, Sherman S, Fogel EL, et al. Tissue sampling at ERCP in suspected malignant biliary strictures (part 2). Gastrointest Endosc. 2002;56:720–30.

    Article  PubMed  Google Scholar 

  50. Cohen MB, Wittchow RJ, Johlin FC, et al. Brush cytology of the extrahepatic biliary tract: comparison of cytologic features of adenocarcinoma and benign biliary strictures. Mod Pathol. 1995;8:498–502.

    PubMed  CAS  Google Scholar 

  51. Gupta DK, Komaromy-Hiller G, Raab SS, et al. Interobserver and intraobserver variability in the cytologic diagnosis of normal and abnormal metaplastic squamous cells in pap smears. Acta Cytol. 2001;45:697–703.

    Article  PubMed  CAS  Google Scholar 

  52. Hahm GK, Niemann TH, Lucas JG, et al. The value of second opinion in gastrointestinal and liver pathology. Arch Pathol Lab Med. 2001;125:736–9.

    PubMed  CAS  Google Scholar 

  53. Logrono R, Waxman I. Interactive role of the cytopathologist in EUS-guided fine needle aspiration: an efficient approach. Gastrointest Endosc. 2001;54:485–90.

    Article  PubMed  CAS  Google Scholar 

  54. Lin A, Jonnalagadda S, Edmundowicz S. Diagnosis of malignant biliary strictures. Tech Gastrointest Endosc. 2002;4:102–12.

    Article  Google Scholar 

  55. Harewood GC, Baron TH, Stadheim LM, et al. Prospective, blinded assessment of factors influencing the accuracy of biliary cytology interpretation. Am J Gastroenterol. 2004;99:1464–9.

    Article  PubMed  Google Scholar 

  56. Rabinovitz M, Zajko AB, Hassanein T, et al. Diagnostic value of brush cytology in the diagnosis of bile duct carcinoma: a study in 65 patients with bile duct strictures. Hepatology. 1990;12:747–52.

    Article  PubMed  CAS  Google Scholar 

  57. Glasbrenner B, Ardan M, Boeck W, et al. Prospective evaluation of brush cytology of biliary strictures during endoscopic retrograde cholangiopancreatography. Endoscopy. 1999;31:712–7.

    Article  PubMed  CAS  Google Scholar 

  58. Ailwala J, Fogel EL, Sherman S, et al. Triple-tissue sampling at ERCP in malignant biliary obstruction. Gastrointest Endosc. 2000;51:383–90.

    Article  Google Scholar 

  59. Lindberg B, Arnelo U, Bergquist A, et al. Diagnosis of biliary strictures in conjunction with endoscopic retrograde cholangiopancreaticography, with special reference to patients with primary sclerosing cholangitis. Endoscopy. 2002;34:909–16.

    Article  PubMed  CAS  Google Scholar 

  60. Lal A, Okonkwo A, Schindler S, et al. Role of biliary brush cytology in primary sclerosing cholangitis. Acta Cytol. 2004;48:9–12.

    Article  PubMed  Google Scholar 

  61. Wu Y, Johlin FC, Rayhill SC, et al. Long-term, tumor-free survival after radiotherapy combining hepatectomy-Whipple en bloc and orthotopic liver transplantation for early-stage hilar cholangiocarcinoma. Liver Transpl. 2008;14:279–86.

    Article  PubMed  Google Scholar 

  62. Moreno Luna LE, Kipp B, Halling KC, et al. Advanced cytologic techniques for the detection of malignant pancreatobiliary strictures. Gastroenterology. 2006;131:1064–72.

    Article  PubMed  Google Scholar 

  63. Muralikrishna P, Madhu K, Aditya A, et al. Peroral cholangioscopy: new approach with a balloon enteroscope. Endoscopy. 2008;40 Suppl 2Suppl 2:E234.

    Article  PubMed  Google Scholar 

  64. Choi HJ, Moon JH, Ko BM, et al. Overtube-balloon-assisted direct peroral cholangioscopy by using an ultra-slim upper endoscope (with videos). Gastrointest Endosc. 2009;69:935–40.

    Article  PubMed  Google Scholar 

  65. El Fouly A, Dechene A, Gerken G. Surveillance and screening of primary sclerosing cholangitis. Dig Dis. 2009;27:526–35.

    Article  PubMed  Google Scholar 

  66. Igarashi Y, Okano N, Ito K, et al. Effectiveness of peroral cholangioscopy and narrow band imaging for endoscopically diagnosing the bile duct cancer. Dig Endosc. 2009;21 Suppl 1Suppl 1:S101–2.

    Article  PubMed  Google Scholar 

  67. Petersen BT. Cholangioscopy for special applications: primary sclerosing cholangitis, liver transplant, and selective duct access. Gastrointest Endosc Clin N Am. 2009;19:579–86.

    Article  PubMed  Google Scholar 

  68. Chang KJ. State of the art lecture: endoscopic ultrasound (EUS) and FNA in pancreatico-biliary tumors. Endoscopy. 2006;38 Suppl 1Suppl 1:S56–60.

    Article  PubMed  Google Scholar 

  69. DeWitt J, Misra VL, Leblanc JK, et al. EUS-guided FNA of proximal biliary strictures after negative ERCP brush cytology results. Gastrointest Endosc. 2006;64:325–33.

    Article  PubMed  Google Scholar 

  70. Kaufman D, Widlus D, Lazinger M, et al. Diagnostic accuracy of Simpson atherectomy catheter biopsy in detecting pancreaticobiliary malignancy. Am J Gastroenterol. 2001;96:1054–8.

    Article  PubMed  CAS  Google Scholar 

  71. Tsukui D, Yano T, Nakazawa K, et al. Rendezvous technique combining double-balloon endoscopy with percutaneous cholangioscopy is useful for the treatment of biliary anastomotic obstruction after liver transplantation (with video). Gastrointest Endosc. 2008;68:1013–5.

    Article  PubMed  Google Scholar 

  72. Kim YS, Gupta K, Mallery S, et al. Endoscopic ultrasound rendezvous for bile duct access using a transduodenal approach: cumulative experience at a single center. A case series. Endoscopy. 2010;42:496–502.

    Article  PubMed  CAS  Google Scholar 

  73. Lee TH, Park SH, Lee SH, et al. Modified rendezvous intrahepatic bile duct cannulation technique to pass a PTBD catheter in ERCP. World J Gastroenterol. 2010;16:5388–90.

    Article  PubMed  Google Scholar 

  74. Weinbren K, Mutum SS. Pathological aspects of cholangiocarcinoma. J Pathol. 1983;139:217–38.

    Article  PubMed  CAS  Google Scholar 

  75. Jarnagin WR, Fong Y, DeMatteo RP, et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg. 2001;234:507–17.

    Article  PubMed  CAS  Google Scholar 

  76. Parikh AA, Abdalla EK, Vauthey JN. Operative considerations in resection of hilar cholangiocarcinoma. HPB (Oxford). 2005;7:254–8.

    Article  Google Scholar 

  77. Edge S, Byrd DR, Compton CC, et al. Perihilar bile ducts. In: Edge S, Byrd DR, Compton CC, editors. AJCC cancer staging handbook. New York: Springer; 2010. p. 263–9.

    Google Scholar 

  78. Paik KY, Choi DW, Chung JC, et al. Improved survival following right trisectionectomy with caudate lobectomy without operative mortality: surgical treatment for hilar cholangiocarcinoma. J Gastrointest Surg. 2008;12:1268–74.

    Article  PubMed  Google Scholar 

  79. Miyazaki M, Kimura F, Shimizu H, et al. One hundred seven consecutive surgical resections for hilar cholangiocarcinoma of Bismuth types II, III, IV between 2001 and 2008. J Hepatobiliary Pancreat Sci. 2010;17:470–5.

    Article  PubMed  Google Scholar 

  80. Shi Z, Yang MZ, He QL, et al. Addition of hepatectomy decreases liver recurrence and leads to long survival in hilar cholangiocarcinoma. World J Gastroenterol. 2009;15:1892–6.

    Article  PubMed  Google Scholar 

  81. Sotiropoulos GC, Lang H, Molmenti EP, et al. Partial or complete mesohepatectomy combined with resection of the hilar bifurcation in cases of Klatskin tumors: a reasonable strategy? Am J Surg. 2009;198:297–8.

    Article  PubMed  Google Scholar 

  82. Unno M, Katayose Y, Rikiyama T, et al. Major hepatectomy for perihilar cholangiocarcinoma. J Hepatobiliary Pancreat Sci. 2010;17:463–9.

    Article  PubMed  Google Scholar 

  83. Nguyen KT, Steel J, Vanounou T, et al. Initial presentation and management of hilar and peripheral cholangiocarcinoma: is a node-positive status or potential margin-positive result a contraindication to resection? Ann Surg Oncol. 2009;16:3308–15.

    Article  PubMed  Google Scholar 

  84. Neuhaus P, Jonas S, Bechstein WO, et al. Extended resections for hilar cholangiocarcinoma. Ann Surg. 1999;230:808–18.

    Article  PubMed  CAS  Google Scholar 

  85. Miyazaki M, Ito H, Nakagawa K, et al. Aggressive surgical approaches to hilar cholangiocarcinoma: hepatic or local resection? Surgery. 1998;123:131–6.

    Article  PubMed  CAS  Google Scholar 

  86. Hemming AW, Reed AI, Howard RJ, et al. Preoperative portal vein embolization for extended hepatectomy. Ann Surg. 2003;237:686–91.

    PubMed  Google Scholar 

  87. McPherson GA, Benjamin IS, Hodgson HJ, et al. Pre-operative percutaneous transhepatic biliary drainage: the results of a controlled trial. Br J Surg. 1984;71:371–5.

    Article  PubMed  CAS  Google Scholar 

  88. Hatfield AR, Tobias R, Terblanche J, et al. Preoperative external biliary drainage in obstructive jaundice. A prospective controlled clinical trial. Lancet. 1982;2:896–9.

    Article  PubMed  CAS  Google Scholar 

  89. Ebata T, Nagino M, Kamiya J, et al. Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases. Ann Surg. 2003;238:720–7.

    Article  PubMed  Google Scholar 

  90. Seyama Y, Kubota K, Sano K, et al. Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Ann Surg. 2003;238:73–83.

    PubMed  Google Scholar 

  91. Belghiti J, Ogata S. Preoperative optimization of the liver for resection in patients with hilar cholangiocarcinoma. HPB (Oxford). 2005;7:252–3.

    Article  Google Scholar 

  92. Kim RD, Kim JS, Watanabe G, et al. Liver regeneration and the atrophy-hypertrophy complex. Semin Intervent Radiol. 2008;25:92–103.

    Article  PubMed  Google Scholar 

  93. Nagino M, Kamiya J, Nishio H, et al. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Ann Surg. 2006;243:364–72.

    Article  PubMed  Google Scholar 

  94. Ogata S, Belghiti J, Farges O, et al. Sequential arterial and portal vein embolizations before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma. Br J Surg. 2006;93:1091–8.

    Article  PubMed  CAS  Google Scholar 

  95. Weber SM, DeMatteo RP, Fong Y, et al. Staging laparoscopy in patients with extrahepatic biliary carcinoma. Analysis of 100 patients. Ann Surg. 2002;235:392–9.

    Article  PubMed  Google Scholar 

  96. Connor S, Barron E, Wigmore SJ, et al. The utility of laparoscopic assessment in the preoperative staging of suspected hilar cholangiocarcinoma. J Gastrointest Surg. 2005;9:476–80.

    Article  PubMed  Google Scholar 

  97. Nimura Y, Hayakawa N, Kamiya J, et al. Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus. World J Surg. 1990;14:535–44.

    Article  PubMed  CAS  Google Scholar 

  98. Mizumoto R, Kawarada Y, Suzuki H. Surgical treatment of hilar carcinoma of the bile duct. Surg Gynecol Obstet. 1986;162:153–8.

    PubMed  CAS  Google Scholar 

  99. Ogura Y, Mizumoto R, Tabata M, et al. Surgical treatment of carcinoma of the hepatic duct confluence: analysis of 55 resected carcinomas. World J Surg. 1993;17:85–92.

    Article  PubMed  CAS  Google Scholar 

  100. Sugiura Y, Nakamura S, Iida S, et al. Extensive resection of the bile ducts combined with liver resection for cancer of the main hepatic duct junction: a cooperative study of the Keio Bile Duct Cancer Study Group. Surgery. 1994;115:445–51.

    PubMed  CAS  Google Scholar 

  101. Rea DJ, Munoz-Juarez M, Farnell MB, et al. Major hepatic resection for hilar cholangiocarcinoma: analysis of 46 patients. Arch Surg. 2004;139:514–23.

    Article  PubMed  Google Scholar 

  102. Gazzaniga GM, Filauro M, Bagarolo C, et al. Surgery for hilar cholangiocarcinoma: an Italian experience. J Hepatobiliary Pancreat Surg. 2000;7:122–7.

    Article  PubMed  CAS  Google Scholar 

  103. Kitagawa Y, Nagino M, Kamiya J, et al. Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent reg­ional and paraaortic node dissection. Ann Surg. 2001;233:385–92.

    Article  PubMed  CAS  Google Scholar 

  104. Heimbach JK, Gores GJ, Haddock MG, et al. Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma. Transplantation. 2006;82:1703–7.

    Article  PubMed  CAS  Google Scholar 

  105. Heimbach JK. Successful liver transplantation for hilar cholangiocarcinoma. Curr Opin Gastroenterol. 2008;24:384–8.

    Article  PubMed  Google Scholar 

  106. Nichols JC, Gores GJ, LaRusso NF, et al. Diagnostic role of serum CA 19-9 for cholangiocarcinoma in patients with primary sclerosing cholangitis. Mayo Clin Proc. 1993;68:874–9.

    Article  PubMed  CAS  Google Scholar 

  107. Levy C, Lymp J, Angulo P, et al. The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis. Dig Dis Sci. 2005;50:1734–40.

    Article  PubMed  CAS  Google Scholar 

  108. Rosen CB, Heimbach JK, Gores GJ. Liver transplantation for cholangiocarcinoma. Transpl Int. 2010;23:692–7.

    Article  PubMed  Google Scholar 

  109. Sasaki A, Aramaki M, Kawano K, et al. Intrahepatic peripheral cholangiocarcinoma: mode of spread and choice of surgical treatment. Br J Surg. 1998;85:1206–9.

    Article  PubMed  CAS  Google Scholar 

  110. Sasaki A, Kawano K, Aramaki M, et al. Correlation between tumor size and mode of spread in mass-forming intrahepatic cholangiocarcinoma. Hepatogastroenterology. 2004;51:224–8.

    PubMed  Google Scholar 

  111. Kaseb A, Thomas M, Curley S. Gallbladder and bile duct cancer. In: Hong W, Bast R, Hait W, et al., editors. Holland frei cancer medicine. 8th ed. Beijing: People’s Medical Publishing House; 2006.

    Google Scholar 

  112. Pascher A, Jonas S, Neuhaus P. Intrahepatic cholangiocarcinoma: indication for transplantation. J Hepatobiliary Pancreat Surg. 2003;10:282–7.

    Article  PubMed  Google Scholar 

  113. Yano Y, Yamamoto J, Kosuge T, et al. Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases. Jpn J Clin Oncol. 2003;33:283–7.

    Article  PubMed  Google Scholar 

  114. Maganty K, Levi D, Moon J, et al. Combined hepatocellular carcinoma and intrahepatic cholangiocarcinoma: outcome after liver transplantation. Dig Dis Sci. 2010;55:3597–601.

    Article  PubMed  Google Scholar 

  115. Chan AC, Lo CM, Ng IO, et al. Liver transplantation for combined hepatocellular cholangiocarcinoma. Asian J Surg. 2007;30:143–6.

    Article  PubMed  Google Scholar 

  116. Kim KH, Lee SG, Park EH, et al. Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma. Ann Surg Oncol. 2009;16:623–9.

    Article  PubMed  Google Scholar 

  117. Liver Cancer Study Group of Japan. Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Ann Surg. 1990;211:277–87.

    Google Scholar 

  118. Maeda T, Adachi E, Kajiyama K, et al. Combined hepatocellular and cholangiocarcinoma: proposed criteria according to cytokeratin expression and analysis of clinicopathologic features. Hum Pathol. 1995;26:956–64.

    Article  PubMed  CAS  Google Scholar 

  119. Kato T, Tsukamoto E, Kuge Y, et al. Clinical role of (18)F-FDG PET for initial staging of patients with extrahepatic bile duct cancer. Eur J Nucl Med Mol Imaging. 2002;29:1047–54.

    Article  PubMed  CAS  Google Scholar 

  120. Anderson CD, Rice MH, Pinson CW, et al. Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma. J Gastrointest Surg. 2004;8:90–7.

    Article  PubMed  Google Scholar 

  121. Breitenstein S, Apestegui C, Clavien PA. Positron emission tomography (PET) for cholangiocarcinoma. HPB (Oxford). 2008;10:120–1.

    Article  CAS  Google Scholar 

  122. Corvera CU, Blumgart LH, Akhurst T, et al. 18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer. J Am Coll Surg. 2008;206:57–65.

    Article  PubMed  Google Scholar 

  123. Seo S, Hatano E, Higashi T, et al. P-glycoprotein expression affects 18F-fluorodeoxyglucose accumulation in hepatocellular carcinoma in vivo and in vitro. Int J Oncol. 2009;34:1303–12.

    PubMed  CAS  Google Scholar 

  124. Gleeson FC, Rajan E, Levy MJ, et al. EUS-guided FNA of regional lymph nodes in patients with unresectable hilar cholangiocarcinoma. Gastrointest Endosc. 2008;67:438–43.

    Article  PubMed  Google Scholar 

  125. Kornberg A, Kupper B, Thrum K, et al. Recurrence-free long-term survival after liver transplantation in patients with 18F-FDG non-avid hilar cholangiocarcinoma on PET. Am J Transplant. 2009;9:2631–6.

    Article  PubMed  CAS  Google Scholar 

  126. Johlin F, Voight M, Wu Y. Surveillance Cytology (SC) in the detection of asymptomatic progression to cholangiocarcinoma (CCC) in patients with primary sclerosing cholangitis (PSC). Hepatology. 1998;28:393A.

    Google Scholar 

  127. De Vreede I, Steers JL, Burch PA, et al. Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma. Liver Transpl. 2000;6:309–16.

    Article  PubMed  Google Scholar 

  128. Heimbach JK, Gores GJ, Haddock MG, et al. Liver transplantation for unresectable perihilar cholangiocarcinoma. Semin Liver Dis. 2004;24:201–7.

    Article  PubMed  Google Scholar 

  129. Hassoun Z, Gores GJ, Rosen CB. Preliminary experience with liver transplantation in selected patients with unresectable hilar cholangiocarcinoma. Surg Oncol Clin N Am. 2002;11:909–21.

    Article  PubMed  Google Scholar 

  130. Sudan D, DeRoover A, Chinnakotla S, et al. Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma. Am J Transplant. 2002;2:774–9.

    Article  PubMed  Google Scholar 

  131. Klempnauer J, Ridder GJ, von Wasielewski R, et al. Resectional surgery of hilar cholangiocarcinoma: a multivariate analysis of prognostic factors. J Clin Oncol. 1997;15:947–54.

    PubMed  CAS  Google Scholar 

  132. American Joint Committee on Cancer. The AJCC Cancer Staging Manual and Handbook. 7th ed. New York: Springer; 2010.

    Google Scholar 

  133. Kawasaki S, Imanura H, Kobayaski A, et al. Results of surgical resection for patients with hilar bile duct cancer. Application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization. Ann Surg. 2003;338:84–92.

    Google Scholar 

Suggested Reading

  • Dinant S, Gerhards MF, Rauws EA. Improved outcome of resection of hilar cholangiocarcinoma (Klatskin tumor). Ann Surg Oncol. 2006;13:872–80.

    Article  PubMed  Google Scholar 

  • Gerhards MF, van Gulik TM, de Wit LT, et al. Evaluation of morbidity and mortality after resection for hilar cholangiocarcinoma—a single center experience. Surgery. 2000;127:395–404.

    Article  PubMed  CAS  Google Scholar 

  • Hemming AW, Reed AI, Fujita S, et al. Surgical management of hilar cholangiocarcinoma. Ann Surg. 2005;241:693–9.

    Article  PubMed  Google Scholar 

  • Jarnagin WR, Bowne W, Klimsgtra DS, et al. Papillary phenotype confers improved survival after resection for hilar cholangiocarcinoma. Ann Surg. 2005;241:703–14.

    Article  PubMed  Google Scholar 

  • Kawarada Y, Das BS, Naganuma T, et al. Surgical treatment of hilar bile duct carcinoma: experience with 25 consecutive hepatectomies. J Gastrointest Surg. 2002;6:617–24.

    Article  PubMed  Google Scholar 

  • Kosuge T, Yamamot J, Shimada K, et al. Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Ann Surg. 1999;230:663–71.

    Article  PubMed  CAS  Google Scholar 

  • Launois B, Reding R, Lebeau G, et al. Surgery for hilar cholangiocarcinoma: French experience in a collective survey of 552 extrahepatic bile duct cancers. J Hepatobiliary Pancreat Surg. 2000;7:128–34.

    Article  PubMed  CAS  Google Scholar 

  • Nakeeb A, Pitt HA, Sohn TA, et al. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg. 1996;224:463–73.

    Article  PubMed  CAS  Google Scholar 

  • Seyama Y, Kubota K, Sano K, et al. Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Ann Surg. 2003;238:720–7.

    Article  Google Scholar 

  • Todoroki T, Kawamoto T, Koike N, et al. Radical resection of hilar bile duct carcinoma and predictors of survival. Br J Surg. 2000;87:306–13.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gastroenterological Surgery, Graduate School of Medicine, Yokohama City University, Yokohama, Japan

    J. J. Schwartz MD

  2. Department of Surgery, University of Utah, Salt Lake City, UT, USA

    J. Sorensen MD & R. Kim MD

Authors
  1. J. J. Schwartz MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Sorensen MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Kim MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. J. Schwartz MD .

Editor information

Editors and Affiliations

  1. , Faculty of Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong, N/A, Hong Kong SAR

    W.Y. Lau

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media Dordrecht and People's Medical Publishing House

About this chapter

Cite this chapter

Schwartz, J.J., Sorensen, J., Kim, R. (2013). Selection of Patients for Liver Resection and Liver Transplantation. In: Lau, W. (eds) Hilar Cholangiocarcinoma. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-6473-6_16

Download citation

  • DOI: https://doi.org/10.1007/978-94-007-6473-6_16

  • Published:

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-007-6472-9

  • Online ISBN: 978-94-007-6473-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation